90% of the developing world and millions of women don't have access to breast cancer early detection. The incidence of breast cancer is expected to continue growing (after doubling in just two decades) and with that the mortality rate mainly due to late stage detection.
With innovative technologies and a passionate team, our mission is to make the hope of early detection a reality.
We thank Empathy Foundation and Maharashtra Gov. for this pioneering initiative
It's good to have partners!
UE LifeSciences welcomes SRL Daignostics, Medall and Metropolis Labs
News & Milestones
learn what are we up to, what's in the news & what's upcoming
Entrepreneurs with social mission
Economic Times, June 28 2016
"The developed world has access to early detection, better treatment and hence the outcomes were fantastic, unlike the low and middle income countries where the survival rate is poor because of lack of early detection"... read more
Hi-Tech At Low Cost
Forbes India, July 2016
$3M investment from Aarin, USF
VC Circle, Sep 14 2015
The company to expand trials of its newly developed hand-held breast health examination device called ‘iBreastExam’ in India. It will also look to set up its manufacturing units and build distribution networks through public and private primary care providers... read more
Mihir Shah, Founder
After witnessing several members of my family & friends get diagnosed with breast cancer, I founded UE LifeSciences in Jan 2009. My singular vision is to make breast cancer early detection possible for women everywhere, regardless of age, color or any other demographic. In the past four years, we have developed two innovations that make me feel very optimistic towards the future.
There are risks and costs to action. But they are far less than the long range risks of comfortable inaction - JFK